April Armstrong, MD interviewed by Brad Glick, DO, MPH, FAAD

January JAAD: Deucravacitnib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week randomized, double-blinded, placebo-controlled hase 3 PO

As a subscriber to Dialogues in Dermatology premium channel, you will receive new podcasts weekly and can earn CME credit. Listen each week as dermatologists discuss clinical treatments and the latest in dermatology. Dialogues in Dermatology is brought to you by the American Academy of Dermatology.

Medicine

Science & Medicine

Health & Fitness

Todd Mollett, MD interviewed by Carlos Garcia, MD, FAAD

Bonus: What’s New in the Management of High-Risk SCC (Sponsored by Regeneron Pharmaceuticals)

Vinh Chung, MD, FAAD interviewed by Lilia M Correa, MD, FAAD

Practice Management Series: Physician Burnout and Wellness

Larry Green, MD, FAAD and Murad Alam, MD, FAAD interviewed by Mona Sadeghpour, MD, FAAD

Bonus: AAD 2024 Election: President-Elect (Dr. Murad Alam) and Vice President-Elect (Dr. Larry Green)

Paul Nghiem, MD, PhD, FAAD interviewed by Olayemi Sokumbi, MD, FAAD

March JAAD: Merkel cell carcinoma recurrence risk estimation is improved by integrating factors beyond cancer stage: a multivariable model and web-based calculator

Elise Olsen, MD, FAAD interviewed by Vineet Mishra, MD, FAAD

January JAAD: Deucravacitnib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week randomized, double-blinded, placebo-controlled hase 3 PO

Download our free app to listen on your phone